About 23% had a FBZDP as first-time prescriber (18 808).
A specialist in general practice as the first-time prescriber was associated with a lower risk compared to doctors without specialty.
However, there may be limited time for prescribers to discuss treatment options if the average time spent with the patient is 12 minutes or less as was found in this study.
Factors related to OAC therapy choice may change over time as prescribers and patients gain more familiarity and experience with the newer OACs, and additional research will be needed to identify predictors of treatment and changes in OAC treatment patterns in the future.
For the prescriber, time is scarce.
The alerts were faxed the following morning (i.e., near-real time) to the prescriber of the second drug of the PDDI.
Analysis of variance (ANOVA) was used to explore whether the number of items prescribed differed according to individual demographic variables such as job title, employer, care setting, and time since qualifying as prescriber.
For the second step, only the significant variables from the prior step as well as all health characteristic information (smoking behavior, exercise behavior, alcohol consumption, BMI, Charlson Comorbidity Index, prescriber type, time since diagnosis, and concomitant treatments) were entered into a multiple regression model.
No difference in the severity of the cases (assessed by SAPS II and SOFA scores) was observed according to the timing of prescription, the type of prescriber, or the time to initiation of AT.
These characteristics are more difficult to detect and need more time and attention from prescribers.
Such data can be compared internally (e.g. over time, between wards, between prescribers, etc).
